These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9831976)

  • 1. Prevention of precipitation of phenytoin in an infusion fluid by hydroxypropyl beta-cyclodextrin.
    McDonald C; Muzumdar PP
    J Clin Pharm Ther; 1998 Jun; 23(3):235-9. PubMed ID: 9831976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and testing of an improved parenteral formulation of phenytoin using 2-hydroxypropyl-beta-cyclodextrin.
    Blanchard J; Ugwu SO; Bhardwaj R; Dorr RT
    Pharm Dev Technol; 2000; 5(3):333-8. PubMed ID: 10934732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of ovine growth hormone with 2-hydroxypropyl-beta-cyclodextrin.
    Simpkins JW
    J Parenter Sci Technol; 1991; 45(6):266-9. PubMed ID: 1802981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization of the neutral and charged forms of 2,4,6-trichlorophenol by beta-cyclodextrin, methyl-beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in water.
    Hanna K; de Brauer C; Germain P
    J Hazard Mater; 2003 Jun; 100(1-3):109-16. PubMed ID: 12835016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs.
    Brewster ME; Hora MS; Simpkins JW; Bodor N
    Pharm Res; 1991 Jun; 8(6):792-5. PubMed ID: 2062811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone.
    Felton LA; Wiley CJ; Godwin DA
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1117-24. PubMed ID: 12455470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 2-hydroxypropyl-beta-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate.
    Usayapant A; Karara AH; Narurkar MM
    Pharm Res; 1991 Dec; 8(12):1495-9. PubMed ID: 1808612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl.
    McCandless R; Yalkowsky SH
    J Pharm Sci; 1998 Dec; 87(12):1639-42. PubMed ID: 10189280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.
    Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids.
    Mura P; Maestrelli F; Cirri M
    Int J Pharm; 2003 Jul; 260(2):293-302. PubMed ID: 12842348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers.
    Alvarez C; Calero J; Menéndez JC; Torrado S; Torrado JJ
    Pharmazie; 2008 Jul; 63(7):511-3. PubMed ID: 18717484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxypropyl-beta-cyclodextrin and its combination with hydroxypropyl-methylcellulose increases aqueous solubility of delta9-tetrahydrocannabinol.
    Jarho P; Pate DW; Brenneisen R; Järvinen T
    Life Sci; 1998; 63(26):PL381-4. PubMed ID: 9877229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-beta-cyclodextrin.
    Pop E; Loftsson T; Bodor N
    Pharm Res; 1991 Aug; 8(8):1044-9. PubMed ID: 1924158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin sodium solubility in three intravenous solutions.
    Pfeifle CE; Adler DS; Gannaway WL
    Am J Hosp Pharm; 1981 Mar; 38(3):358-62. PubMed ID: 7223749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cyclodextrins enhance bioavailability of pilocarpine.
    Freedman KA; Klein JW; Crosson CE
    Curr Eye Res; 1993 Jul; 12(7):641-7. PubMed ID: 8222723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.
    Pitha J; Gerloczy A; Olivi A
    J Pharm Sci; 1994 Jun; 83(6):833-7. PubMed ID: 9120816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.
    Narisawa S; Stella VJ
    J Pharm Sci; 1998 Aug; 87(8):926-30. PubMed ID: 9687335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilities of trimethoprim and sulfamethoxazole at various pH values and crystallization of trimethoprim from infusion fluids.
    McDonald C; Faridah
    J Parenter Sci Technol; 1991; 45(3):147-51. PubMed ID: 1886043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the solubility of several aromatics and terpenes in aqueous hydroxypropyl-beta-cyclodextrin with steric and hydrophobicity parameters.
    Demian BA
    Carbohydr Res; 2000 Oct; 328(4):635-9. PubMed ID: 11093722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.